How are laboratories tackling misinformation?
Drug Discovery Today
SEPTEMBER 16, 2022
Why opening up communication channels can stop the spread of misinformation
Sat.Sep 10, 2022 - Fri.Sep 16, 2022
113 
The Pulse of Electronic Benefit Verification Solutions: Know the Facts
Drug Channels
SEPTEMBER 16, 2022
Today’s guest post comes from Edward Hensley, Chief Commercial Officer at AssistRx. Edward compares the pros and cons of electronic benefit verification using artificial intelligence, direct connectivity, or data connectivity. He also describes the circumstances where each solution provides the greatest value. To learn more, download AssistRx’s free eBook: Specialty Drug Patient Support Programs: 2022 Progress Report.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Which pharmaceutical companies have the most drug patents in Ireland?
Drug Patent Watch
SEPTEMBER 15, 2022
This chart shows the pharmaceutical companies with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.
The right questions to ask about clinical trial compensation
Antidote
SEPTEMBER 12, 2022
There are many factors one should consider before deciding to enroll in a clinical trial. Though every clinical trial is designed to help researchers advance their knowledge about a specific condition, the details regarding a study’s duration, risks, benefits, and required time commitment can vary. When determining how to participate in clinical trials, these elements are all good things to discuss with the research team to determine if a study is a good fit.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Can You Prevent Alzheimer’s Disease?
Olympian Clinical Research
SEPTEMBER 16, 2022
Nearly 6.2 million Americans were living with Alzheimer’s disease in 2021, according to the Centers for Disease Control and Prevention (CDC). Alzheimer’s disease is the seventh leading cause of death in the United States and is a devastating disease that can rob people of their memories and lives. But what if there were steps you could take to potentially prevent Alzheimer’s from happening in the first place?
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
Which pharmaceutical drugs have the most drug patents in Singapore?
Drug Patent Watch
SEPTEMBER 16, 2022
This chart shows the drugs with the most patents in Singapore. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Singapore? appeared first on DrugPatentWatch - Make Better Decisions.
Using Whole Genome Sequencing to Better Understand PDX Genomic Profiles
Crown Bioscience
SEPTEMBER 15, 2022
Using whole genome sequencing to better understand PDX genomic profiles is a highly comprehensive method for analyzing whole genomes. By incorporating WGS into preclinical tumor studies, the genomic and pathogenic features of cancers can be better understood, and translational biomarkers can be identified more efficiently.
What is the patient recruitment process for clinical trials?
Antidote
SEPTEMBER 15, 2022
Successful clinical trial patient recruitment is a multi-step process that is worth taking the time to thoroughly understand. Clinical trial recruitment companies often make mention of thorough research, rigorous testing, and continuous optimization — but what does that mean in practical terms?
NEW: The Drug Channels 2023 Video Webinar Series
Drug Channels
SEPTEMBER 14, 2022
I invite you to join me for three new video webinars during 2023. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. During these events, I'll address the latest issues confronting the U.S. drug channel. Topics will be determined based on what’s happening—trends, policy changes, company announcements, and more.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
New patent for Azurity drug EPRONTIA
Drug Patent Watch
SEPTEMBER 15, 2022
Annual Drug Patent Expirations for EPRONTIA Eprontia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. The generic ingredient in EPRONTIA…. The post New patent for Azurity drug EPRONTIA appeared first on DrugPatentWatch - Make Better Decisions.
Using AI to Find New Antibiotics Still a Work in Progress
NIH Director's Blog: Drug Discovery
SEPTEMBER 13, 2022
Each year, more than 2.8 million people in the United States develop bacterial infections that don’t respond to treatment and sometimes turn life-threatening [1]. Their infections are antibiotic-resistant, meaning the bacteria have changed in ways that allow them to withstand our current widely used arsenal of antibiotics. It’s a serious and growing health-care problem here and around the world.
Lessons Learned on Preparing to Weather the Inevitable Challenges in Biotech
LifeSciVC
SEPTEMBER 15, 2022
By Joshua Brumm, CEO of Dyne Therapeutics, as part of the From The Trenches feature of LifeSciVC By all accounts, 2022 did not start according to plan for the biotech industry. The U.S. economy and growth stocks struggled with the broader biotech index down by more than 45 percent through the first half of the year. Throughout my career in biotech, I have learned that this industry is filled with twists and turns and, at times, setbacks.
How pharma can overcome inflation
Pharma Manufacturing
SEPTEMBER 14, 2022
Hint: It’s not by raising prices
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Which pharmaceutical companies have the most SPCs in Finland?
Drug Patent Watch
SEPTEMBER 14, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
More on Comparative Warnings
Drug & Device Law
SEPTEMBER 15, 2022
A little over a year ago, we discussed one of the best decisions we had ever read on why comparative risk claims – premised on a manufacturer’s alleged failure to warn that a competing product was supposedly “safer” – are both statistically invalid and practically impossible. That decision, Nelson v. C.R. Bard, Inc. , 553 F. Supp.3d 343 (S.D. Miss. 2021), explained at length both how product “comparisons,” if based on the FDA’s voluntary “MAUDE” adverse event reporting system are inherently sus
New patent for Abbvie Inc drug VENCLEXTA
Drug Patent Watch
SEPTEMBER 14, 2022
Annual Drug Patent Expirations for VENCLEXTA Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents…. The post New patent for Abbvie Inc drug VENCLEXTA appeared first on DrugPatentWatch - Make Better Decisions.
Which pharmaceutical companies have the most SPCs in Italy?
Drug Patent Watch
SEPTEMBER 13, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Italy? appeared first on DrugPatentWatch - Make Better Decisions.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
New patent expiration for Novartis drug CIPRODEX
Drug Patent Watch
SEPTEMBER 13, 2022
Annual Drug Patent Expirations for CIPRODEX Ciprodex is a drug marketed by Novartis and is included in one NDA. It is available from three suppliers. There are four patents protecting…. The post New patent expiration for Novartis drug CIPRODEX appeared first on DrugPatentWatch - Make Better Decisions.
New patent for Emd Serono drug MAVENCLAD
Drug Patent Watch
SEPTEMBER 13, 2022
Annual Drug Patent Expirations for MAVENCLAD Mavenclad is a drug marketed by Emd Serono Inc and is included in one NDA. It is available from one supplier. There are four…. The post New patent for Emd Serono drug MAVENCLAD appeared first on DrugPatentWatch - Make Better Decisions.
New patent for Eyepoint Pharms drug YUTIQ
Drug Patent Watch
SEPTEMBER 13, 2022
Annual Drug Patent Expirations for YUTIQ Yutiq is a drug marketed by Eyepoint Pharms and is included in one NDA. There is one patent protecting this drug. This drug has…. The post New patent for Eyepoint Pharms drug YUTIQ appeared first on DrugPatentWatch - Make Better Decisions.
Which pharmaceutical drugs have the most drug patents in Lithuania?
Drug Patent Watch
SEPTEMBER 12, 2022
This chart shows the drugs with the most patents in Lithuania. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Lithuania? appeared first on DrugPatentWatch - Make Better Decisions.
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Which pharmaceutical companies have the most SPCs in Sweden?
Drug Patent Watch
SEPTEMBER 11, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Sweden. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.
New patent expiration for Bausch drug VANOS
Drug Patent Watch
SEPTEMBER 11, 2022
Annual Drug Patent Expirations for VANOS Vanos is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are three patents protecting…. The post New patent expiration for Bausch drug VANOS appeared first on DrugPatentWatch - Make Better Decisions.
New patent expiration for Glaxo Grp drug BREO ELLIPTA
Drug Patent Watch
SEPTEMBER 11, 2022
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…. The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.
New patent expiration for Glaxosmithkline drug ANORO ELLIPTA
Drug Patent Watch
SEPTEMBER 11, 2022
Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…. The post New patent expiration for Glaxosmithkline drug ANORO ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA
Drug Patent Watch
SEPTEMBER 11, 2022
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…. The post New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA appeared first on DrugPatentWatch - Make Better Decisions.
Let's personalize your content